Tokyo Tape
Sign in
← Toho Holdings

Quarterly report · Q2

8129.TEDINET S100PLCG
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥679.7bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥1.27T2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥620.8bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥4.1bn2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥1.9bn2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥7.4bn2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥18.2bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.8bn2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥6.0bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥5.1bn2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥3.6bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥13.4bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.3bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥3.6bn2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥3.3bn2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥740.6bnat 2022-09-30Cons.Assets
Total assets¥702.4bnat 2022-03-31Cons.Assets
Total assets¥695.9bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥495.0bnat 2022-09-30Cons.Liabilities
Total liabilities¥461.1bnat 2022-03-31Cons.Liabilities
Net assets / equity¥245.6bnat 2022-09-30Cons.Net assets
Net assets / equity¥241.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥240.7bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥102.1bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥94.3bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥97.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥90.0bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥97.1bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥88.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥10.7bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥16.3bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥11.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥407m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥11.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.4bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥4.5bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.2bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥51.012022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.792022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥189.72021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥46.392021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.842021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥46.882022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥174.482021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥42.622021-04-01 → 2021-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio33.1%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio34.3%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.5%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥28.3bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥28.3bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥850m
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue2022-04-01 → 2022-09-30¥45.1bn
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2022-04-01 → 2022-09-30¥45.1bn
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥3m
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2022-04-01 → 2022-09-30¥878m
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2022-04-01 → 2022-09-30¥4.8bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.1bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥3.7bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2022-04-01 → 2022-09-30¥478m
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue2022-04-01 → 2022-09-30¥654.8bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue external2022-04-01 → 2022-09-30¥631.0bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥23.8bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentsegment profit2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥3.3bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.5bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥782m
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥246m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥708.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥679.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥28.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥4.9bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥28.3bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥28.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥996m
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue2021-04-01 → 2021-09-30¥45.5bn
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue external2021-04-01 → 2021-09-30¥45.4bn
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥5m
jpcrp040300-q2r_E02608-000Dispensing Pharmacyreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue2021-04-01 → 2021-09-30¥4.0bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue external2021-04-01 → 2021-09-30¥819m
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥3.2bn
jpcrp040300-q2r_E02608-000Medical Products Manufacturing And Salesreportable segmentsegment profit2021-04-01 → 2021-09-30¥312m
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue2021-04-01 → 2021-09-30¥597.0bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue external2021-04-01 → 2021-09-30¥572.6bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥24.4bn
jpcrp040300-q2r_E02608-000Medical Products Retailreportable segmentsegment profit2021-04-01 → 2021-09-30¥1.1bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue2021-04-01 → 2021-09-30¥2.7bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue external2021-04-01 → 2021-09-30¥2.0bn
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥667m
jpcrp040300-q2r_E02608-000Other Related Businessreportable segmentsegment profit2021-04-01 → 2021-09-30¥100m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥649.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥620.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥28.3bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥2.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 580
ItemContextValueUnit
Cash and depositsPrior1YearInstant94256000000JPY
Cash and depositsCurrentQuarterInstant102124000000JPY
Notes and accounts receivable tradePrior1YearInstant301601000000JPY
Notes and accounts receivable tradeCurrentQuarterInstant325931000000JPY
Merchandise and finished goodsPrior1YearInstant80169000000JPY
Merchandise and finished goodsCurrentQuarterInstant82219000000JPY
Raw materials and suppliesPrior1YearInstant194000000JPY
Raw materials and suppliesCurrentQuarterInstant184000000JPY
Other caPrior1YearInstant37175000000JPY
Other caCurrentQuarterInstant41295000000JPY
Allowance for doubtful accounts caPrior1YearInstant-290000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-296000000JPY
Current assetsPrior1YearInstant513107000000JPY
Current assetsCurrentQuarterInstant551459000000JPY
Property plant and equipmentPrior1YearInstant94653000000JPY
Property plant and equipmentCurrentQuarterInstant92085000000JPY
GoodwillPrior1YearInstant733000000JPY
GoodwillCurrentQuarterInstant668000000JPY
Other iaPrior1YearInstant4443000000JPY
Other iaCurrentQuarterInstant4525000000JPY
Intangible assetsPrior1YearInstant5177000000JPY
Intangible assetsCurrentQuarterInstant5193000000JPY
Investment securitiesPrior1YearInstant78742000000JPY
Investment securitiesCurrentQuarterInstant81720000000JPY
Other ioaPrior1YearInstant12547000000JPY
Other ioaCurrentQuarterInstant11938000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-1851000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-1746000000JPY
Investments and other assetsPrior1YearInstant89438000000JPY
Investments and other assetsCurrentQuarterInstant91911000000JPY
Noncurrent assetsPrior1YearInstant189268000000JPY
Noncurrent assetsCurrentQuarterInstant189190000000JPY
AssetsPrior1YearInstant702376000000JPY
AssetsCurrentQuarterInstant740650000000JPY
Notes and accounts payable tradePrior1YearInstant370012000000JPY
Notes and accounts payable tradeCurrentQuarterInstant407002000000JPY
Short term loans payablePrior1YearInstant6545000000JPY
Short term loans payableCurrentQuarterInstant2876000000JPY
Current portion of bondsPrior1YearInstant－JPY
Current portion of bondsCurrentQuarterInstant20013000000JPY
Income taxes payablePrior1YearInstant5416000000JPY
Income taxes payableCurrentQuarterInstant2731000000JPY
Provision for bonusesPrior1YearInstant3252000000JPY
Provision for bonusesCurrentQuarterInstant3373000000JPY
Provision for directors bonusesPrior1YearInstant53000000JPY
Provision for directors bonusesCurrentQuarterInstant21000000JPY
Asset retirement obligations clPrior1YearInstant4000000JPY
Asset retirement obligations clCurrentQuarterInstant－JPY
Other clPrior1YearInstant17535000000JPY
Other clCurrentQuarterInstant16773000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass